Skip to content

Study on the Intervention Effect of Electroacupuncture at Tiaoshen Points on Hyperarousal in Patients with Chronic Insomnia and Its Brain Functional Mechanism

Study on the Intervention Effect of Electroacupuncture at Tiaoshen Points on Hyperarousal in Patients with Chronic Insomnia and Its Brain Functional Mechanism

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000495
Enrollment
Unknown
Registered
2025-03-10
Start date
2025-03-20
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic insomnia

Interventions

Fake electroacupuncture Tiaoshen point group:After acupuncture Baihui Shenmen and Neiguan electroacupuncture is not treated in essence only connected with electroacupuncture no electricity in which th
Electroacupuncture fake tiaoshen point group:Baihui Shenmen Neiguan beside the non-meridian non-collaterals shallow thorn. Needle selection electroacupuncture site treatment frequency and cycle were t
Electroacupuncture Tiaoshen point group:Acupuncture Baihui Shenmen Neiguan except Baihui are double-sided point selection after entering the needle Baihui Shenmen Neiguan is connected with the positiv

Sponsors

Dongfang Hospital Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Meeting the diagnostic criteria for chronic insomnia disorder; (2) PSQI score = 7; HAS score = 32; (3) Age ranging from 18 to 65 years old; (4) Capable of cooperating with all scale assessments and sample collections; (5) Having signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients suffering from malignant tumors and serious physical diseases such as heart liver kidney and nervous system; (2) Patients with secondary insomnia caused by anxiety depression and other mental disorders; (3) People with substance use disorders (including alcohol tobacco caffeine sedatives psychoactive drugs etc.) Addiction or abuse); (4) SQ =5 points; SBQ =3 scores; IRLS =10 score; (5) long-term use of sedative sleeping pills and antidepressants and other psychotropic drugs; (6) GAD-7=10 score; PHQ-9=10 scores; (7) Women during pregnancy lactation and preparation for pregnancy; Subjects who meet any of the above criteria will be excluded.

Design outcomes

Primary

MeasureTime frame
PSQI;

Secondary

MeasureTime frame
PSAS HAS ESS PHQ-9 GAD-7;fNIRS;Serological mechanism index;

Countries

China

Contacts

Public ContactXINGJIA

Dongfang Hospital Beijing University of Chinese Medicine

dfyyxingjia@163.com13810680063

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026